Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Clinical management of breast cancer (BC) metastasis remains an unmet need as it accounts for 90% of BC-associated mortality. Although the luminal subtype, which represents >70% of BC cases, is generally associated with a favorable outcome, it is susceptible to metastatic relapse as late as 15 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Tundidor, Isabel, Seijo-Vila, Marta, Blasco-Benito, Sandra, Rubert-Hernández, María, Adámez, Sandra, Andradas, Clara, Manzano, Sara, Álvarez-López, Isabel, Sarasqueta, Cristina, Villa-Morales, María, González-Lois, Carmen, Ramírez-Medina, Esther, Almoguera, Belén, Sánchez-López, Antonio J., Bindila, Laura, Hamann, Sigrid, Arnold, Norbert, Röcken, Christoph, Heras-Murillo, Ignacio, Sancho, David, Moreno-Bueno, Gema, Caffarel, María M., Guzmán, Manuel, Sánchez, Cristina, Pérez-Gómez, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229544/
https://www.ncbi.nlm.nih.gov/pubmed/37253733
http://dx.doi.org/10.1038/s41467-023-38750-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229544/
https://www.ncbi.nlm.nih.gov/pubmed/37253733
http://dx.doi.org/10.1038/s41467-023-38750-9

Ejemplares similares